GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.
| Subscribe To Our Free Newsletter |
